The PI3K AKT Pathway as a Target for Cancer Treatment von Mayer, Ingrid A, Arteaga, Carlos L

Volltext

Targeting the PI3K/AKT/mTOR Pathway in Hormone-Positive Breast Cancer von Nunnery, Sara E., Mayer, Ingrid A.

Volltext

PI3K/AKT/mTOR: role in breast cancer progression, drug resistance, and treatment von Guerrero-Zotano, Angel, Mayer, Ingrid A., Arteaga, Carlos L.

Volltext

Alpelisib for PIK3CA-Mutated, Hormone Receptor–Positive Advanced Breast Cancer von André, Fabrice, Ciruelos, Eva, Rubovszky, Gabor, Campone, Mario, Loibl, Sibylle, Rugo, Hope S, Iwata, Hiroji, Conte, Pierfranco, Mayer, Ingrid A, Kaufman, Bella, Yamashita, Toshinari, Lu, Yen-Shen, Inoue, Kenichi, Takahashi, Masato, Pápai, Zsuzsanna, Longin, Anne-Sophie, Mills, David, Wilke, Celine, Hirawat, Samit, Juric, Dejan

Volltext

New Strategies for Triple-Negative Breast Cancer—Deciphering the Heterogeneity von MAYER, Ingrid A, ABRAMSON, Vandana G, LEHMANN, Brian D, PIETENPOL, Jennifer A

Volltext

Resistance to Trastuzumab in Breast Cancer von POHLMANN, Paula R, MAYER, Ingrid A, MERNAUGH, Ray

Volltext

Prevention of everolimus-related stomatitis in women with hormone receptor-positive, HER2-negative metastatic breast cancer using dexamethasone mouthwash (SWISH): a single-arm, pha... von Rugo, Hope S, Dr Prof, Seneviratne, Lasika, MD, Beck, J Thaddeus, MD, Glaspy, John A, Prof, Peguero, Julio A, MD, Pluard, Timothy J, MD, Dhillon, Navneet, MD, Hwang, Leon Christopher, MD, Nangia, Chaitali, MD, Mayer, Ingrid A, MD, Meiller, Timothy F, Prof, Chambers, Mark S, Prof, Sweetman, Robert W, MD, Sabo, J Randy, MPH, Litton, Jennifer K, MD

Volltext

Pictilisib for oestrogen receptor-positive, aromatase inhibitor-resistant, advanced or metastatic breast cancer (FERGI): a randomised, double-blind, placebo-controlled, phase 2 tri... von Krop, Ian E, Dr, Mayer, Ingrid A, MD, Ganju, Vinod, FRACP, Dickler, Maura, MD, Johnston, Stephen, MD, Morales, Serafin, MD, Yardley, Denise A, MD, Melichar, Bohuslav, Prof, Forero-Torres, Andres, MD, Lee, Soo Chin, MRCP, de Boer, Richard, FRACP, Petrakova, Katarina, PhD, Vallentin, Susanne, MD, Perez, Edith A, MD, Piccart, Martine, Prof, Ellis, Matthew, Prof, Winer, Eric, Prof, Gendreau, Steven, PhD, Derynck, Mika, MD, Lackner, Mark, PhD, Levy, Gallia, MD, Qiu, Jiaheng, PhD, He, Jing, MD, Schmid, Peter, Prof

Volltext

Multiparametric Magnetic Resonance Imaging for Predicting Pathological Response After the First Cycle of Neoadjuvant Chemotherapy in Breast Cancer von Li, Xia, Abramson, Richard G, Arlinghaus, Lori R, Kang, Hakmook, Chakravarthy, Anuradha Bapsi, Abramson, Vandana G, Farley, Jaime, Mayer, Ingrid A, Kelley, Mark C, Meszoely, Ingrid M, Means-Powell, Julie, Grau, Ana M, Sanders, Melinda, Yankeelov, Thomas E

Volltext

Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03) von Gnant, Michael, Dueck, Amylou C, Frantal, Sophie, Martin, Miguel, Burstein, Hal J, Greil, Richard, Fox, Peter, Wolff, Antonio C, Chan, Arlene, Winer, Eric P, Pfeiler, Georg, Miller, Kathy D, Colleoni, Marco, Suga, Jennifer M, Rubovsky, Gabor, Bliss, Judith M, Mayer, Ingrid A, Singer, Christian F, Nowecki, Zbigniew, Hahn, Olwen, Thomson, Jacqui, Wolmark, Norman, Amillano, Kepa, Rugo, Hope S, Steger, Guenther G, Hernando Fernández de Aránguiz, Blanca, Haddad, Tufia C, Perelló, Antonia, Bellet, Meritxell, Fohler, Hannes, Metzger Filho, Otto, Jallitsch-Halper, Anita, Solomon, Kadine, Schurmans, Céline, Theall, Kathy P, Lu, Dongrui R, Tenner, Kathleen, Fesl, Christian, DeMichele, Angela, Mayer, Erica L

Volltext

A Phase Ib Study of Alpelisib (BYL719), a PI3Kα-Specific Inhibitor, with Letrozole in ER+/HER2- Metastatic Breast Cancer von Mayer, Ingrid A, Abramson, Vandana G, Formisano, Luigi, Balko, Justin M, Estrada, Mónica V, Sanders, Melinda E, Juric, Dejan, Solit, David, Berger, Michael F, Won, Helen H, Li, Yisheng, Cantley, Lewis C, Winer, Eric, Arteaga, Carlos L

Volltext

Efficacy and Safety of Anti-Trop-2 Antibody Drug Conjugate Sacituzumab Govitecan (IMMU-132) in Heavily Pretreated Patients With Metastatic Triple-Negative Breast Cancer von Bardia, Aditya, Mayer, Ingrid A, Diamond, Jennifer R, Moroose, Rebecca L, Isakoff, Steven J, Starodub, Alexander N, Shah, Nikita C, O'Shaughnessy, Joyce, Kalinsky, Kevin, Guarino, Michael, Abramson, Vandana, Juric, Dejan, Tolaney, Sara M, Berlin, Jordan, Messersmith, Wells A, Ocean, Allyson J, Wegener, William A, Maliakal, Pius, Sharkey, Robert M, Govindan, Serengulam V, Goldenberg, David M, Vahdat, Linda T

Volltext

Effect of Metformin vs Placebo on Invasive Disease–Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial von Goodwin, Pamela J, Chen, Bingshu E, Gelmon, Karen A, Whelan, Timothy J, Ennis, Marguerite, Lemieux, Julie, Ligibel, Jennifer A, Hershman, Dawn L, Mayer, Ingrid A, Hobday, Timothy J, Bliss, Judith M, Rastogi, Priya, Rabaglio-Poretti, Manuela, Mukherjee, Som D, Mackey, John R, Abramson, Vandana G, Oja, Conrad, Wesolowski, Robert, Thompson, Alastair M, Rea, Daniel W, Stos, Paul M, Shepherd, Lois E, Stambolic, Vuk, Parulekar, Wendy R

Volltext

Multicenter Phase II Study of Neoadjuvant Lapatinib and Trastuzumab With Hormonal Therapy and Without Chemotherapy in Patients With Human Epidermal Growth Factor Receptor 2–Overexp... von RIMAWI, Mothaffar F, MAYER, Ingrid A, SCHIFF, Rachel, KENT OSBORNE, C, CHANG, Jenny C, FORERO, Andres, NANDA, Rita, GOETZ, Matthew P, RODRIGUEZ, Angel A, PAVLICK, Anne C, TAO WANG, HILSENBECK, Susan G, GUTIERREZ, Carolina

Volltext

Randomized Phase III Postoperative Trial of Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemothera... von Mayer, Ingrid A., Zhao, Fengmin, Arteaga, Carlos L., Symmans, William F., Park, Ben H., Burnette, Brian L., Tevaarwerk, Amye J., Garcia, Sofia F., Smith, Karen L., Makower, Della F., Block, Margaret, Morley, Kimberly A., Jani, Chirag R., Mescher, Craig, Dewani, Shabana J., Tawlik, Bernard, Flaum, Lisa E., Mayer, Erica L., Sikov, William M., Rodler, Eve T., Wagner, Lynne, DeMichele, Angela M., Sparano, Joseph A., Wolff, Antonio C., Miller, Kathy D.

Volltext

Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline von Van Poznak, Catherine, Somerfield, Mark R, Bast, Robert C, Cristofanilli, Massimo, Goetz, Matthew P, Gonzalez-Angulo, Ana M, Hicks, David G, Hill, Elizabeth G, Liu, Minetta C, Lucas, Wanda, Mayer, Ingrid A, Mennel, Robert G, Symmans, William F, Hayes, Daniel F, Harris, Lyndsay N

Volltext

Sacituzumab Govitecan-hziy in Triple-Negative Breast Cancer. Reply von Bardia, Aditya, Mayer, Ingrid A, Kalinsky, Kevin

Volltext

A Randomized Phase II Neoadjuvant Study of Cisplatin, Paclitaxel With or Without Everolimus in Patients with Stage II/III Triple-Negative Breast Cancer (TNBC): Responses and Long-t... von Jovanović, Bojana, Mayer, Ingrid A, Mayer, Erica L, Abramson, Vandana G, Bardia, Aditya, Sanders, Melinda E, Kuba, M Gabriela, Estrada, Monica V, Beeler, J Scott, Shaver, Timothy M, Johnson, Kimberly C, Sanchez, Violeta, Rosenbluth, Jennifer M, Dillon, Patrick M, Forero-Torres, Andres, Chang, Jenny C, Meszoely, Ingrid M, Grau, Ana M, Lehmann, Brian D, Shyr, Yu, Sheng, Quanhu, Chen, Sheau-Chiann, Arteaga, Carlos L, Pietenpol, Jennifer A

Volltext

Sacituzumab govitecan (IMMU‐132), an anti‐Trop‐2‐SN‐38 antibody‐drug conjugate for the treatment of diverse epithelial cancers: Safety and pharmacokinetics von Ocean, Allyson J., Starodub, Alexander N., Bardia, Aditya, Vahdat, Linda T., Isakoff, Steven J., Guarino, Michael, Messersmith, Wells A., Picozzi, Vincent J., Mayer, Ingrid A., Wegener, William A., Maliakal, Pius, Govindan, Serengulam V., Sharkey, Robert M., Goldenberg, David M.

Volltext

Inhibition of the PI3K/mTOR Pathway in Breast Cancer to Enhance Response to Immune Checkpoint Inhibitors in Breast Cancer von Yan, Chi, Yang, Jinming, Saleh, Nabil, Chen, Sheau-Chiann, Ayers, Gregory D., Abramson, Vandana G., Mayer, Ingrid A., Richmond, Ann

Volltext